{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:37:05Z","timestamp":1770287825784,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007816","name":"Alcon","doi-asserted-by":"publisher","award":["IIT # 25962225"],"award-info":[{"award-number":["IIT # 25962225"]}],"id":[{"id":"10.13039\/100007816","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Posterior capsule opacification (PCO) after cataract surgery is influenced by intraocular lens (IOL) design and material. The following is an ex vivo comparison of PCO between the Clareon vs. the AcrySof IOL in human capsular bags.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Twenty cadaver capsular bags from 10 human donors were used, with the novel hydrophobic IOL (Clareon, CNA0T0) being implanted in one eye and the other eye of the same donor receiving the AcrySof IOL (SN60WF) following phacoemulsification cataract surgery. Five capsular bags of 3 donors served as controls without IOL. Cellular growth of lens epithelial cells was photo-documented daily. The primary endpoint was the time until full coverage of the posterior capsule by cells. Furthermore, immunofluorescence staining of capsular bags for the fibrotic markers f-actin, fibronectin, alpha smooth muscle actin, and collagen type 1 were performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The new Clareon IOL did not show any disadvantages in terms of days until full cell coverage of the posterior capsule in comparison to the AcrySof (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.99). Both, the Clareon (<jats:italic>p<\/jats:italic>\u2009=\u20090.01, 14.8\u2009days) and the AcrySof IOL (<jats:italic>p<\/jats:italic>\u2009=\u20090.005, 15.7\u2009days) showed a slower PCO development in comparison to the control (8.6\u2009days). The fibrotic markers f-actin, fibronectin, alpha smooth muscle actin, and collagen type 1 were equally distributed between the two IOLs and differed from the control.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>A comparable performance has been found in the ex vivo formation of PCO between the two IOLs. Long-term clinical studies are necessary to reach final conclusions.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12886-020-01349-5","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T08:02:54Z","timestamp":1582790574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Evaluation of posterior capsule opacification of the Alcon Clareon IOL vs the Alcon Acrysof IOL using a human capsular bag model"],"prefix":"10.1186","volume":"20","author":[{"given":"Anna","family":"Hillenmayer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian M.","family":"Wertheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Kassumeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annabel","family":"von Studnitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaus","family":"Luft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Ohlmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siegfried","family":"Priglinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8891-4875","authenticated-orcid":false,"given":"Wolfgang J.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,27]]},"reference":[{"issue":"1","key":"1349_CR1","doi-asserted-by":"publisher","first-page":"e0210205","DOI":"10.1371\/journal.pone.0210205","volume":"14","author":"MY Han","year":"2019","unstructured":"Han MY, Yu AH, Yuan J, Cai XJ, Ren JB. Effect of anterior capsule polish on visual function: a meta-analysis. PLoS One. 2019;14(1):e0210205.","journal-title":"PLoS One"},{"issue":"2","key":"1349_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.exer.2008.10.016","volume":"88","author":"IM Wormstone","year":"2009","unstructured":"Wormstone IM, Wang L, Liu CS. Posterior capsule opacification. Exp Eye Res. 2009;88(2):257\u201369.","journal-title":"Exp Eye Res"},{"issue":"3","key":"1349_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1006\/exer.2001.1153","volume":"74","author":"IM Wormstone","year":"2002","unstructured":"Wormstone IM. Posterior capsule opacification: a cell biological perspective. Exp Eye Res. 2002;74(3):337\u201347.","journal-title":"Exp Eye Res"},{"key":"1349_CR4","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.2147\/OPTH.S175060","volume":"12","author":"A Maxwell","year":"2018","unstructured":"Maxwell A, Suryakumar R. Long-term effectiveness and safety of a three-piece acrylic hydrophobic intraocular lens modified with hydroxyethyl-methacrylate: an open-label, 3-year follow-up study. Clin Ophthalmol. 2018;12:2031\u20137.","journal-title":"Clin Ophthalmol"},{"key":"1349_CR5","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.2147\/OPTH.S161380","volume":"12","author":"M Von Tress","year":"2018","unstructured":"Von Tress M, Marotta JS, Lane SS, Sarangapani R. A meta-analysis of Nd:YAG capsulotomy rates for two hydrophobic intraocular lens materials. Clin Ophthalmol. 2018;12:1125\u201336.","journal-title":"Clin Ophthalmol"},{"key":"1349_CR6","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.2147\/OPTH.S48824","volume":"7","author":"PJ Morgan-Warren","year":"2013","unstructured":"Morgan-Warren PJ, Smith JA. Intraocular lens-edge design and material factors contributing to posterior-capsulotomy rates: comparing Hoya FY60aD, PY60aD, and AcrySof SN60WF. Clin Ophthalmol. 2013;7:1661\u20137.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"1349_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/09286580490515116","volume":"11","author":"GU Auffarth","year":"2004","unstructured":"Auffarth GU, Brezin A, Caporossi A, Lafuma A, Mendicute J, Berdeaux G, Smith AF, European PCOSG. Comparison of Nd : YAG capsulotomy rates following phacoemulsification with implantation of PMMA, silicone, or acrylic intra-ocular lenses in four European countries. Ophthalmic Epidemiol. 2004;11(4):319\u201329.","journal-title":"Ophthalmic Epidemiol"},{"issue":"1","key":"1349_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ophtha.2004.07.032","volume":"112","author":"O Findl","year":"2005","unstructured":"Findl O, Menapace R, Sacu S, Buehl W, Rainer G. Effect of optic material on posterior capsule opacification in intraocular lenses with sharp-edge optics: randomized clinical trial. Ophthalmology. 2005;112(1):67\u201372.","journal-title":"Ophthalmology"},{"issue":"1","key":"1349_CR9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0886-3350(02)01422-0","volume":"29","author":"RJ Linnola","year":"2003","unstructured":"Linnola RJ, Sund M, Ylonen R, Pihlajaniemi T. Adhesion of soluble fibronectin, vitronectin, and collagen type IV to intraocular lens materials. J Cataract Refract Surg. 2003;29(1):146\u201352.","journal-title":"J Cataract Refract Surg"},{"issue":"7","key":"1349_CR10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3928\/1542-8877-19980701-10","volume":"29","author":"O Nishi","year":"1998","unstructured":"Nishi O, Nishi K, Sakanishi K. Inhibition of migrating lens epithelial cells at the capsular bend created by the rectangular optic edge of a posterior chamber intraocular lens. Ophthalmic Surg Lasers. 1998;29(7):587\u201394.","journal-title":"Ophthalmic Surg Lasers"},{"issue":"3","key":"1349_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ophtha.2016.11.010","volume":"124","author":"A Haripriya","year":"2017","unstructured":"Haripriya A, Chang DF, Vijayakumar B, Niraj A, Shekhar M, Tanpreet S, Aravind S. Long-term posterior capsule Opacification reduction with square-edge Polymethylmethacrylate intraocular Lens: randomized controlled study. Ophthalmology. 2017;124(3):295\u2013302.","journal-title":"Ophthalmology"},{"issue":"14","key":"1349_CR12","doi-asserted-by":"publisher","first-page":"6408","DOI":"10.1167\/iovs.17-22555","volume":"58","author":"C Wertheimer","year":"2017","unstructured":"Wertheimer C, Kassumeh S, Piravej NP, Nilmayer O, Braun C, Priglinger C, Luft N, Wolf A, Mayer WJ, Priglinger SG, et al. The intraocular Lens as a drug delivery device: in vitro screening of pharmacologic substances for the prophylaxis of posterior capsule Opacification. Invest Ophthalmol Vis Sci. 2017;58(14):6408\u201318.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"1349_CR13","first-page":"906","volume":"37","author":"CS Liu","year":"1996","unstructured":"Liu CS, Wormstone IM, Duncan G, Marcantonio JM, Webb SF, Davies PD. A study of human lens cell growth in vitro. A model for posterior capsule opacification. Invest Ophthalmol Vis Sci. 1996;37(5):906\u201314.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"1349_CR14","doi-asserted-by":"publisher","first-page":"7057","DOI":"10.1167\/iovs.14-15302","volume":"55","author":"JA Eldred","year":"2014","unstructured":"Eldred JA, Spalton DJ, Wormstone IM. An in vitro evaluation of the Anew Zephyr open-bag IOL in the prevention of posterior capsule opacification using a human capsular bag model. Invest Ophthalmol Vis Sci. 2014;55(11):7057\u201364.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"1349_CR15","doi-asserted-by":"publisher","first-page":"e874","DOI":"10.1111\/aos.13759","volume":"96","author":"C Wertheimer","year":"2018","unstructured":"Wertheimer C, Kueres A, Siedlecki J, Braun C, Kassumeh S, Wolf A, Mayer W, Priglinger C, Priglinger S, Eibl-Lindner K. The intraocular lens as a drug delivery device for an epidermal growth factor-receptor inhibitor for prophylaxis of posterior capsule opacification. Acta Ophthalmol. 2018;96(7):e874\u201382.","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"1349_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1167\/iovs.18-25930","volume":"60","author":"JA Eldred","year":"2019","unstructured":"Eldred JA, Zheng J, Chen S, Wormstone IM. An in vitro human Lens capsular bag model adopting a graded culture regime to assess putative impact of IOLs on PCO formation. Invest Ophthalmol Vis Sci. 2019;60(1):113\u201322.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"1349_CR17","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jcrs.2010.05.006","volume":"36","author":"G Cleary","year":"2010","unstructured":"Cleary G, Spalton DJ, Zhang JJ, Marshall J. In vitro lens capsule model for investigation of posterior capsule opacification. J Cataract Refract Surg. 2010;36(8):1249\u201352.","journal-title":"J Cataract Refract Surg"},{"issue":"8","key":"1349_CR18","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.ophtha.2008.01.002","volume":"115","author":"T Kohnen","year":"2008","unstructured":"Kohnen T, Fabian E, Gerl R, Hunold W, Hutz W, Strobel J, Hoyer H, Mester U. Optic edge design as long-term factor for posterior capsular opacification rates. Ophthalmology. 2008;115(8):1308\u201314 1314 e1301\u20131303.","journal-title":"Ophthalmology"},{"issue":"12","key":"1349_CR19","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.jcrs.2018.07.040","volume":"44","author":"L Werner","year":"2018","unstructured":"Werner L, Ellis N, Heczko JB, Ong M, Jain R, Wolfe P, Peterson T, Jiang B, Mamalis N. In vivo evaluation of a new hydrophobic acrylic intraocular lens in the rabbit model. J Cataract Refract Surg. 2018;44(12):1497\u2013502.","journal-title":"J Cataract Refract Surg"},{"issue":"10","key":"1349_CR20","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1038\/s41433-018-0131-2","volume":"32","author":"PG Ursell","year":"2018","unstructured":"Ursell PG, Dhariwal M, Majirska K, Ender F, Kalson-Ray S, Venerus A, Miglio C, Bouchet C. Three-year incidence of Nd:YAG capsulotomy and posterior capsule opacification and its relationship to monofocal acrylic IOL biomaterial: a UK real world evidence study. Eye (Lond). 2018;32(10):1579\u201389.","journal-title":"Eye (Lond)"},{"issue":"7","key":"1349_CR21","first-page":"2301","volume":"43","author":"IM Wormstone","year":"2002","unstructured":"Wormstone IM, Tamiya S, Anderson I, Duncan G. TGF-beta2-induced matrix modification and cell transdifferentiation in the human lens capsular bag. Invest Ophthalmol Vis Sci. 2002;43(7):2301\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"1349_CR22","doi-asserted-by":"publisher","first-page":"e95262","DOI":"10.1371\/journal.pone.0095262","volume":"9","author":"J Gerhart","year":"2014","unstructured":"Gerhart J, Greenbaum M, Scheinfeld V, Fitzgerald P, Crawford M, Bravo-Nuevo A, Pitts M, George-Weinstein M. Myo\/Nog cells: targets for preventing the accumulation of skeletal muscle-like cells in the human lens. PLoS One. 2014;9(4):e95262.","journal-title":"PLoS One"},{"issue":"5","key":"1349_CR23","first-page":"1130","volume":"41","author":"JM Marcantonio","year":"2000","unstructured":"Marcantonio JM, Rakic JM, Vrensen GF, Duncan G. Lens cell populations studied in human donor capsular bags with implanted intraocular lenses. Invest Ophthalmol Vis Sci. 2000;41(5):1130\u201341.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1349_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.preteyeres.2017.08.001","volume":"60","author":"DY Shu","year":"2017","unstructured":"Shu DY, Lovicu FJ. Myofibroblast transdifferentiation: the dark force in ocular wound healing and fibrosis. Prog Retin Eye Res. 2017;60:44\u201365.","journal-title":"Prog Retin Eye Res"},{"issue":"10","key":"1349_CR25","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1167\/iovs.07-0091","volume":"48","author":"N Gotoh","year":"2007","unstructured":"Gotoh N, Perdue NR, Matsushima H, Sage EH, Yan Q, Clark JI. An in vitro model of posterior capsular opacity: SPARC and TGF-beta2 minimize epithelial-to-mesenchymal transition in lens epithelium. Invest Ophthalmol Vis Sci. 2007;48(10):4679\u201387.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"1349_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.exer.2008.08.002","volume":"88","author":"BP Danysh","year":"2009","unstructured":"Danysh BP, Duncan MK. The lens capsule. Exp Eye Res. 2009;88(2):151\u201364.","journal-title":"Exp Eye Res"},{"issue":"6","key":"1349_CR27","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0886-3350(13)80655-4","volume":"20","author":"T Ishibashi","year":"1994","unstructured":"Ishibashi T, Hatae T, Inomata H. Collagen types in human posterior capsule opacification. J Cataract Refract Surg. 1994;20(6):643\u20136.","journal-title":"J Cataract Refract Surg"},{"issue":"5","key":"1349_CR28","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3109\/02713683.2013.853194","volume":"39","author":"A Shimada","year":"2014","unstructured":"Shimada A, Miyata Y, Kosano H. Type I collagen accelerates the spreading of lens epithelial cells through the expression and activation of matrix metalloproteinases. Curr Eye Res. 2014;39(5):460\u201371.","journal-title":"Curr Eye Res"},{"issue":"1","key":"1349_CR29","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1167\/iovs.14-14934","volume":"56","author":"A Tiwari","year":"2014","unstructured":"Tiwari A, Ram J, Luthra-Guptasarma M. Targeting the fibronectin type III repeats in tenascin-C inhibits epithelial-mesenchymal transition in the context of posterior capsular opacification. Invest Ophthalmol Vis Sci. 2014;56(1):272\u201383.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"1349_CR30","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1136\/bjo.81.10.907","volume":"81","author":"M Quinlan","year":"1997","unstructured":"Quinlan M, Wormstone IM, Duncan G, Davies PD. Phacoemulsification versus extracapsular cataract extraction: a comparative study of cell survival and growth on the human capsular bag in vitro. Br J Ophthalmol. 1997;81(10):907\u201310.","journal-title":"Br J Ophthalmol"},{"key":"1349_CR31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.exer.2015.04.021","volume":"142","author":"IM Wormstone","year":"2016","unstructured":"Wormstone IM, Eldred JA. Experimental models for posterior capsule opacification research. Exp Eye Res. 2016;142:2\u201312.","journal-title":"Exp Eye Res"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01349-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-020-01349-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01349-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,16]],"date-time":"2022-10-16T18:33:22Z","timestamp":1665945202000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-020-01349-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,27]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1349"],"URL":"https:\/\/doi.org\/10.1186\/s12886-020-01349-5","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,27]]},"assertion":[{"value":"6 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental procedures and the tissue harvesting process included proper consent and approval, complied with the Declaration of Helsinki and were approved by the institutional review board. Ethics approval for the project of the isolation, study and cultivation of postmortem human eye tissue, number 734\u201316, was granted by the Ethics committee by the Ludwig-Maximilian University Munich, (Head: Prof. Dr. Eisenmenger) (Ethikkommission bei der Medizinischen Fakult\u00e4t der LMU M\u00fcnchen, Pettenkoferstr. 8, 80336 M\u00fcnchen, Germany). Consent for the donation and scientific use of the human donor tissue in conformity with the declaration of Helsinki was given either prior to their death by the donors themselves or post-mortem by the next of kin.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AH; CW; SK; AvS; NL; AO: The authors declare that they have no competing interests.SP: consultant or advisory board for Abbott, Alcon, Geuder, Oculus, Schwind, STAAR, TearLab, Thieme Compliance, Ziemer, Zeiss; Research Funding: Abbott, Alcon, Hoya, Oculentis, Oculus, Schwind, Zeiss.WM: consultant and\/ or recipient of financial support from Alcon, Novartis, Zeiss Meditec, Ziemer, Allergan, Oculentis, Bausch&Lomb, Heidelberg Engineering, \u00d6rtli, Staar Surgical.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}